Vascular Graft Market Expected to Increase at a CAGR 5.0% through 2016 to 2024

By -
Vascular graft has been a prosthetic of choice among the vascular and other cardiovascular surgeons worldwide due to its strong, inert and biocompatible design which also varies in sizes and configurations in order to improve vascular access. The rise in vascular graft usage has been increased due to increase in cardiovascular diseases and diabetes. Increase in geriatric population, demand of new technological advancements in vascular access, rise in demand of vascular grafts among vascular patients can also accelerate the growth in vascular graft market. Risk of infection due to diabetes mellitus and immune response can increase some serious complications such as sepsis, amputation, disruption of infected anastomotic rigid line with a rupture, etc. can restrain the market growth.
The global vascular graft market is forecast to reach US$3.29 bn by the end of 2024, from US$2.15 bn in 2015. If these figures hold true, the global vascular grafts market will exhibit a CAGR of 5.0% between 2016 and 2024.

Hospitals Emerge as Leading End Users of Vascular Grafts
Based on product, the vascular graft market is segmented as an endovascular stent graft, peripheral vascular graft, hemodialysis access graft, bypass graft and others. The endovascular stent graft segment dominated the global vascular graft market accounting for the share of 41.0% in 2015 as these devices are mostly utilized by the vascular surgeons for abnormal aortic disorders or an aneurysm caused due to cardiovascular disorders or diabetes and smoking. The hemodialysis segment is also expected to register the fastest growth during the forecast period due to increase in the number of diabetes patients. Bypass graft segment is projected to grow with a second highest CAGR between 2016 and 2024 due to increase in number of incidences of coronary artery diseases caused due to increase in obesity and unhealthy food habits.

Vascular grafts are used by various end users including hospitals, ambulatory surgical centres, specialty clinics, cardiac catheterization laboratories, and others. The hospital end user segment held the largest market share in 2015 owing to increasing incidence of cardiovascular disease, introduction of technological modification on grafts by different key players in the form of usage of different sources. The segment is also projected to grow at the fastest CAGR within the end user segment. The major factor driving the hospital end user segment is that most of the vascular graft with latest technological source & design availability in hospitals.

Comments

Post a Comment

Popular posts from this blog

Heart risk calculator due for an update

By -
Image
Over 11 million Americans are at high risk of having a heart attack or  stroke  in the next 10 years — at least, that’s what the numbers say. The equation doctors use to estimate  cardiovascular  risk is prone to miscalculation, according to a new study, meaning patients may be popping daily aspirin or statins at the wrong dosage. The stakes are higher for African-Americans. With the old equation, 1 in 29 African-Americans may be incorrectly labeled very low or very high risk, according to the study. For example, a 46-year-old black man was estimated to have a 40 percent lower chance of having a heart attack or stroke than a white man of the same age and in identical health. In general, African-Americans are at higher risk of cardiovascular conditions than Caucasians, so miscalculations shouldn’t be taken lightly. The heart risk calculator transforms patient information — age, gender, race,  cholesterol  levels, blood pressure, prescriptions, and whether they are diabetic or a
Read more

Global Neurovascular Devices Market Growth Opportunities 2018 – , Medtronic, and Stryker Corporation

By -
Image
The research report on “Global Neurovascular Devices Market” reveals exclusive information regarding the leading players of neurovascular devices market, product launches, market segments, technological development,  neurovascular devices  industry chain structure and policies by region, along with five-year forecasts to assess how the market is anticipated to grow. neurovascular devices report delivers complete details about revenue generation by differing profiles of top leaders of neurovascular devices market. It also displays a comprehensive study of global neurovascular devices market competitive landscape, market drivers, challenges, and constraints, operator case studies, key developments and neurovascular devices market tendencies, future guidelines, methods and worth chain. Thereafter neurovascular devices report gives a precise summary of various growth opportunities, inventive business strategies, neurovascular devices product scope, market size, growth estimations,
Read more

How to Mend a Broken Heart

By -
Image
A newborn’s heart is about the size of its fist, the valves inside minuscule. This presents an issue for surgeons trying to help infants born with heart defects. Traditional mechanical replacement valves are larger than a newborn’s, so they may compress the coronary artery or trigger problems in the heart’s electrical system. And surgical repair is tricky because many infants have too little valve tissue to stitch together. “No matter what we try, it just doesn’t work,” says Carl Backer (pictured at top), head of cardiovascular surgery at the Ann & Robert H. Lurie Children’s Hospital of Chicago. Now there’s a more viable option: In March, the Food and Drug Administration approved the world’s smallest mechanical heart valve. Backer, who took the 15-millimeter device manufactured by Abbott Laboratories through clinical trials, first implanted one of the dime-size valves in 2011 under a “compassionate use” exemption, which allows doctors access to devices still in the process of ear
Read more